| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 01/05/2024 | 12:30 | Business Wire | Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization | NYSE:JNJ | Johnson and Johnson |
| 22/04/2024 | 22:30 | Business Wire | Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) | NYSE:JNJ | Johnson and Johnson |
| 19/04/2024 | 13:31 | IH Market News | Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More | NYSE:JNJ | Johnson and Johnson |
| 17/04/2024 | 12:59 | IH Market News | US Index Futures See Gains, Oil Prices Dip | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 22:33 | IH Market News | U.S. Stocks Finish Lackluster Session Narrowly Mixed | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 16:46 | Business Wire | CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 15:52 | IH Market News | J&J’s Q1 2024 sales rise 2.3% to $21.4 billion | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 15:09 | IH Market News | Dow Looks To Snap Six-Day Losing Streak As UnitedHealth Surges | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 13:19 | IH Market News | U.S. Index Futures Signal Mixed Trading, Oil Prices Dip | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 13:18 | IH Market News | Ericsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More News | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 12:25 | Business Wire | Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% | NYSE:JNJ | Johnson and Johnson |
| 16/04/2024 | 12:20 | Business Wire | Johnson & Johnson Reports Q1 2024 Results | NYSE:JNJ | Johnson and Johnson |
| 15/04/2024 | 22:38 | IH Market News | U.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales Data | NYSE:JNJ | Johnson and Johnson |
| 09/04/2024 | 00:06 | Business Wire | Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference | NYSE:JNJ | Johnson and Johnson |
| 06/04/2024 | 05:21 | PR Newswire (US) | CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy | NYSE:JNJ | Johnson and Johnson |
| 05/04/2024 | 20:55 | PR Newswire (US) | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc. | NYSE:JNJ | Johnson and Johnson |
| 05/04/2024 | 13:38 | IH Market News | Apple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More Updates | NYSE:JNJ | Johnson and Johnson |
| 05/04/2024 | 12:31 | Business Wire | Johnson & Johnson to Acquire Shockwave Medical | NYSE:JNJ | Johnson and Johnson |
| 05/04/2024 | 00:01 | Business Wire | Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation | NYSE:JNJ | Johnson and Johnson |
| 02/04/2024 | 22:30 | Business Wire | Johnson & Johnson to Participate in the BofA Securities Health Care Conference | NYSE:JNJ | Johnson and Johnson |
| 28/03/2024 | 14:48 | IH Market News | Walgreens Slashes Annual Profit Forecast; MillerKnoll Nosedives 17% on Bleak 4Q Outlook, and Latest News | NYSE:JNJ | Johnson and Johnson |
| 27/03/2024 | 11:54 | IH Market News | GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News | NYSE:JNJ | Johnson and Johnson |
| 12/03/2024 | 14:15 | GlobeNewswire Inc. | Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge | NYSE:JNJ | Johnson and Johnson |
| 11/03/2024 | 21:30 | Business Wire | Johnson & Johnson to Host Investor Conference Call on First-Quarter Results | NYSE:JNJ | Johnson and Johnson |
| 07/03/2024 | 22:58 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:JNJ | Johnson and Johnson |
| 07/03/2024 | 14:33 | Business Wire | Johnson & Johnson Completes Acquisition of Ambrx | NYSE:JNJ | Johnson and Johnson |
| 01/03/2024 | 21:59 | PR Newswire (US) | RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations | NYSE:JNJ | Johnson and Johnson |
| 20/02/2024 | 22:26 | PR Newswire (US) | TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myeloma | NYSE:JNJ | Johnson and Johnson |
| 16/02/2024 | 22:12 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NYSE:JNJ | Johnson and Johnson |
| 16/02/2024 | 12:08 | IH Market News | Nike Workforce Reduction, The Trade Desk Soars 19% on $606 Million Revenue, and Latest News | NYSE:JNJ | Johnson and Johnson |